In the latest session, Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed at $3.99 down -1.24% from its previous closing price of $4.04. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 518530 shares were traded.
Ratios:
For a deeper understanding of Atea Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.24 and its Current Ratio is at 18.24. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 06, 2022, Morgan Stanley Downgraded its rating to Underweight which previously was Equal-Weight and also lowered its target price recommendation from $14 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 01 when Sommadossi Jean-Pierre sold 56,910 shares for $3.85 per share. The transaction valued at 218,819 led to the insider holds 116,557 shares of the business.
Horga Maria Arantxa sold 15,870 shares of AVIR for $60,963 on Feb 01. The Chief Medical Officer now owns 25,664 shares after completing the transaction at $3.84 per share. On Feb 01, another insider, Corcoran Andrea, who serves as the insider of the company, sold 15,843 shares for $3.84 each. As a result, the insider received 60,915 and left with 670,208 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 335.82M and an Enterprise Value of -239.89M. Its current Enterprise Value per Revenue stands at 58.97 whereas that against EBITDA is 1.46.
Stock Price History:
Over the past 52 weeks, AVIR has reached a high of $5.19, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is 3.7776, while the 200-Day Moving Average is calculated to be 3.5058.
Shares Statistics:
For the past three months, AVIR has traded an average of 490.04K shares per day and 419.72k over the past ten days. A total of 83.44M shares are outstanding, with a floating share count of 73.79M. Insiders hold about 12.33% of the company’s shares, while institutions hold 64.13% stake in the company. Shares short for AVIR as of Feb 15, 2024 were 1.62M with a Short Ratio of 3.31, compared to 3.73M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.94% and a Short% of Float of 2.53%.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.61 for the current quarter, with a high estimate of -$0.57 and a low estimate of -$0.63, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.62 and low estimates of -$0.75.
Analysts are recommending an EPS of between -$2.5 and -$3.03 for the fiscal current year, implying an average EPS of -$2.76. EPS for the following year is -$2.92, with 3 analysts recommending between -$2.5 and -$3.14.
